Introduction
Persistent left superior vena cava (PLSVC) is the most common congenital abnormality of the thoracic venous system with an estimated prevalence of 0.3e0.5% in the general population. 1 Fetuses with PLSVC typically have associated congenital heart diseases (CHDs; 80e87%), extracardiac anomalies (60%), and chromosomal aberrations (9%), with trisomy 18 and trisomy 21 as the most common karyotypes. 2, 3 Overall, 90% of cases of fetal PLSVC combined with a chromosomal defect are reported to have CHD and extracardiac defects. 4 We herein report a rare case of a fetus with PLSVC as well as trisomy 21 without any other malformations.
Case Report
A 33-year-old Chinese woman (gravida 1, para 0) naturally conceived a singleton with normal nuchal translucency and serum Down syndrome screening in prenatal care. At 24 weeks' gestation, the fetus was found to have dilated coronary sinus with a diameter of 5 mm, draining blood toward the right atrium, and left-sided superior vena cava with a diameter of 2 mm on the left side of the pulmonary artery by ultrasound ( Figure S1 ). No other cardiac and extracardiac anomalies were detected by detailed followup ultrasound evaluation. Given the possibility of PLSVC and chromosomal aberration, the couple was recommended amniocentesis for fetal karyotype, which they refused.
The pregnancy proceeded without complications. The neonate was delivered at 38 gestational weeks and 5 days: birth weight was 2940 g with Apgar scores of 10, 10, and 10 at 1 minute, 5 minutes, and 10 minutes, respectively. Umbilical cord blood was taken at the same time for chromosomal analysis with the couple's permission. Karyotype test of cord blood showed 47,XX,þ21. Two days after the delivery, echocardiogram and color Doppler imaging were performed to assess the neonatal heart. The results showed dilated coronary sinus (7 mm) draining venous blood toward the right atrium and left-sided superior vena cava with a diameter of 5 mm draining into the dilated vessel.
Discussion
PLSVC is usually found in the fetus during prenatal ultrasound or in individuals during placement of a pacemaker, catheterization for cardiac resynchronization pacemaker therapy implantation, hemodialysis catheter placement, and cardiac surgery. The reported prevalence is 0.3e0.5% in the general population, and 2e11% among patients with CHD. 1 The incidence of fetal PLSVC is reported to be 0.7e0.9%, which is higher than that in the general population, and this could be because the studies were conducted in the high-risk population (including fetuses with CHD and chromosomal abnormalities). 2e4 The association between chromosomal aberration and PLSVC was first reported by Wald et al in 1969. 5 Du et al 4 reported that the incidence of PLSVC in fetuses with chromosomal abnormalities is approximately 0.78%, but the true incidence remains unknown because nearly 20% of fetuses with PLSVC in their study lacked karyotype data. Berg et al 3 and Galindo et al 6 reported that 9% of fetuses with PLSVC also had chromosomal disorders. The reported chromosomal anomalies and other complications are shown in Table 1 . Trisomy 18 and trisomy 21 were the most common karyotypes. The mortality of PLSVC associated with chromosomal disorders remains unknown because a majority of parents decide to terminate pregnancy after diagnosis.
Congenital cardiac defect and extracardiac anomalies are frequently detected in PLSVC fetuses with chromosomal aberration. Some clinicians advocated that CHD and extracardiac anomalies were more directly associated with chromosomal disorders rather than PLSVC. 3, 6 However, we found cases with chromosomal aberrations and PLSVC in the literature and also in our case. Du et al 4 found in a prenatal study that among 20 fetuses with PLSVC and chromosomal aberrations, 90% (18/20) were complicated with cardiac or extracardiac anomalies and 10% (2/20) had isolated PLSVC with no other anomalies. In our case, trisomy 21 was detected in the neonate along with PLSVC as an isolated malformation. Similarly, in Barrea et al's 7 report, chromosomal disorders were present in five of 15 PLSVC fetuses without any other cardiac defect. One fetus with trisomy 21 had PLSVC as an isolated malformation and the other four had combined extracardiac malformations. Based on previously published data and our case, chromosomal aberrations were detected in 41 fetuses with PLSVC and approximately 10% (4/41) were isolated PLSVC with no other malformations. The other 37 cases had cardiac and/ or extracardiac anomalies. Except for PLSVC and chromosomal aberrations, the other malformations in 37 cases are summarized in Table 1 . This incidence was consistent with Du et al's 4 study, but the case numbers are limited, and more data are needed to assess the association of PLSVC with a chromosomal disorder.
PLSVC is more common in chromosomally abnormal fetuses than in normal fetuses. Our patient took the triple serum Down syndrome screening test [free beta-human chorionic gonadotropin (bhCG), alpha-fetoprotein (AFP), and unconjugated estriol (uE3)] in the second trimester and the result was negative. The estimated sensitivity and specificity of the triple test (free bhCG, AFP, and uE3) in the second-trimester serum Down syndrome screening are 81.5% and 97.9%, respectively. 11 Given the possibility of false-negative result from serum testing, we suggested the patient to undergo amniocentesis for karyotype. However, the couple refused. Karyotype test of cord blood showed 47,XX,þ21 after birth. Some clinicians also advocated that fetal karyotyping should be routinely offered with the prenatal detection of PLSVC. We hypothesized that although additional fetal defects were absent, PLSVC may still be an indicator of chromosomal aberration, and fetal karyotype analysis should be performed during pregnancy with the couple's consent.
In conclusion, PLSVC is associated with chromosomal disorder even when additional fetal defects are absent. Once PLSVC is detected, chromosomal analysis and a detailed cardiac and extracardiac examination should be highly considered.
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